Literature DB >> 17383949

The bone-protective effect of the phytoestrogen genistein is mediated via ER alpha-dependent mechanisms and strongly enhanced by physical activity.

T Hertrampf1, M J Gruca, J Seibel, U Laudenbach, K H Fritzemeier, P Diel.   

Abstract

Reduced estrogen levels occurring during menopause in women are accompanied by a variety of disorders, e.g. hot flushes, depressions, osteoporosis, increase in body weight and reduced movement drive. The phytoestrogen genistein (GEN) has been demonstrated to have a significant bone-protective potency. In order to study the ER subtype-specific effects of this phytoestrogen on bone in an animal model, ovariectomized (OVX) female Wistar rats were either treated with 17beta-estradiol (E(2)) (4 microg/kg/day), the ER alpha-specific agonist (ALPHA) 16 alpha-LE(2) (10 microg/kg/day), the ER beta-specific agonist (BETA) 8 beta-VE(2) (100 microg/kg/day) or GEN (10 mg/kg/day) for 3 weeks. Vehicle-treated OVX animals served as controls. All animals had the opportunity of voluntary wheel running. Movement activity, changes of body weight and trabecular bone mineral density (BMD) in the tibia were analyzed. E(2) and ALPHA treatment, but not treatment with BETA, significantly increased the movement activity of OVX rats. Treatment with GEN resulted in a significant decrease of movement activity as compared to OVX animals. Bone mineral density in the trabecular area of the tibia and the expression of bone morphogenetic protein-2 (BMP-2) were significantly reduced in OVX- and BETA-treated rats as compared to rats substituted with E(2), ALPHA and GEN. The bone-protective effect of ALPHA was antagonized by co-treatment with the pure antiestrogen Faslodex (ICI). In order to distinguish hormone-dependent effects from those of exercise, we performed an additional experiment where the animals had no opportunity of wheel running. The results demonstrate that physically inactive rats have a stronger decrease of bone mineral density than physically active animals. Very surprisingly, our data demonstrate that GEN has no bone-protective activity in the absence of physical activity. In contrast, ALPHA and E(2) are bone-protective in the presence and absence of physical activity. In conclusion, our data provide evidence that the effects of E(2) on body weight, movement drive and protection of bone mineral density are mediated via ER alpha, whereas activation of ER beta has only a limited effect. Our data also indicate that the bone-protective effects of GEN may be mediated via ER alpha-dependent mechanisms and that physical activity has a strong impact on the bone-protective potency of this phytoestrogen.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17383949     DOI: 10.1016/j.bone.2007.02.006

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  21 in total

Review 1.  Effects of isoflavones on breast tissue and the thyroid hormone system in humans: a comprehensive safety evaluation.

Authors:  S Hüser; S Guth; H G Joost; S T Soukup; J Köhrle; L Kreienbrock; P Diel; D W Lachenmeier; G Eisenbrand; G Vollmer; U Nöthlings; D Marko; A Mally; T Grune; L Lehmann; P Steinberg; S E Kulling
Journal:  Arch Toxicol       Date:  2018-08-21       Impact factor: 5.153

2.  Premature T cell senescence in Ovx mice is inhibited by repletion of estrogen and medicarpin: a possible mechanism for alleviating bone loss.

Authors:  A M Tyagi; K Srivastava; J Kureel; A Kumar; A Raghuvanshi; D Yadav; R Maurya; A Goel; D Singh
Journal:  Osteoporos Int       Date:  2011-05-12       Impact factor: 4.507

3.  The EPI bioassay identifies natural compounds with estrogenic activity that are potent inhibitors of androgenic pathways in human prostate stromal and epithelial cells.

Authors:  Günter Vollmer; Janina Helle; Hakima Amri; Xunxian Liu; Julia T Arnold
Journal:  J Steroid Biochem Mol Biol       Date:  2011-12-22       Impact factor: 4.292

4.  Genistein, a phytoestrogen, improves total cholesterol, and Synergy, a prebiotic, improves calcium utilization, but there were no synergistic effects.

Authors:  LeeCole L Legette; Wang-Hee Lee; Berdine R Martin; Jon A Story; Ali Arabshahi; Stephen Barnes; Connie M Weaver
Journal:  Menopause       Date:  2011-08       Impact factor: 2.953

5.  Dose-dependent effects of genistein on bone homeostasis in rats' mandibular subchondral bone.

Authors:  Yong-qi Li; Xiang-hui Xing; Hui Wang; Xi-li Weng; Shi-bin Yu; Guang-ying Dong
Journal:  Acta Pharmacol Sin       Date:  2011-11-28       Impact factor: 6.150

6.  Inhibitory effects of Leonurus sibiricus on weight gain after menopause in ovariectomized and high-fat diet-fed mice.

Authors:  Jangseon Kim; Mi Hye Kim; You Yeon Choi; Jongki Hong; Woong Mo Yang
Journal:  J Nat Med       Date:  2016-02-22       Impact factor: 2.343

7.  Estrogen-mimicking isoflavone genistein prevents bone loss in a rat model of obstructive sleep apnea-hypopnea syndrome.

Authors:  Lige Song; Xiao Liang; Yun Zhou
Journal:  Int J Clin Exp Pathol       Date:  2014-03-15

8.  Effects of genistein on vertebral trabecular bone microstructure, bone mineral density, microcracks, osteocyte density, and bone strength in ovariectomized rats.

Authors:  Ruchun Dai; Yulin Ma; Zhifeng Sheng; Yan Jin; Yuhai Zhang; Lingna Fang; Huijie Fan; Eryuan Liao
Journal:  J Bone Miner Metab       Date:  2008-07-04       Impact factor: 2.626

9.  Analysis of the effects of oestrogen receptor alpha (ERalpha)- and ERbeta-selective ligands given in combination to ovariectomized rats.

Authors:  T Hertrampf; J Seibel; U Laudenbach; K H Fritzemeier; P Diel
Journal:  Br J Pharmacol       Date:  2008-02-04       Impact factor: 8.739

10.  Long-term exposure to genistein improves insulin secretory function of pancreatic beta-cells.

Authors:  Zhuo Fu; Dongmin Liu
Journal:  Eur J Pharmacol       Date:  2009-06-18       Impact factor: 4.432

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.